Kate Dingwall

Kate Dingwall currently serves as the Senior Vice President of Development Operations at Zura Bio Limited, a position held since March 2025. Prior to this role, Kate held multiple leadership positions at Adaptimmune, notably as Vice President of Clinical Development Operations and Vice President of Clinical Science and Operations from October 2020 to February 2025. Kate's experience also includes serving as Senior Director of Immuno-Oncology Program Management and Section Director of Oncology Program Management at AstraZeneca from November 2017 to October 2020.